Use this URL to cite or link to this record in EThOS:
Title: Phosphodiesterase expression during the progression of prostate cancer : the significance of PDE4D7
Author: Henderson, David James Peter
Awarding Body: University of Glasgow
Current Institution: University of Glasgow
Date of Award: 2012
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Restricted access.
Access from Institution:
3',5'-cyclic adenosine monophosphate (cAMP) is an important second messenger molecule involved in various signalling responses. cAMP signalling is balanced by the activity of adenylyl cyclase enzymes which catalyse the formation of cAMP from ATP, and the activity of phosphodiesterase enzymes (PDEs) which represent the only means by which cAMP is degraded. A complex balance of synthesis and degradation is underpinned by the expression of multiple cAMP PDE families and splice variants. This allows the cell type secific targeting of PDE isoforms to discreet intracellular signalling complexes. The outcome of this differential patterning of expression is a dynamic and compartmentalised web of cyclic nucleotide gradients that modulate responses to extra-cellular stimuli. Compartmentalization of signalling cascades and cAMP gradients allow multiple differing signal transduction events to occur simultaneously and controls cAMP signalling in time and space within the crowded milieu of intracellular molecular interaction. The PDE isoform expression pattern within human prostate tumours has never been fully described. I have addressed this by reporting a PDE profile for 10 androgen-sensitive and 9 androgen-insensitive cell lines and xenografts. I describe that the PDE4D sub-family is dysregulated in androgen independent disease. In particular I show that the PDE4D isoforms PDE4D3, PDE4D4 and PDE4D7 are significantly down-regulated. PDE4D7 was observed to contribute the largest degree of expression and most dramatic down-regulation of any PDE4 isoform and was therefore chosen for further study. Within this thesis, I describe my efforts to characterise PDE4D7 in the context of the human prostate. I describe its sub-cellular localisation and show it contributes a significant proportion of rolipram sensitive PDE activity at the plasma membrane of AS VCaP cells. The transcriptional regulation of PDE4D7 was also investigated and I found that PDE4D7 is regulated independently of the androgen signalling axis, and that it's genetic overlap with PART-1 poses intriguing possibilities for further research.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: RC0254 Neoplasms. Tumors. Oncology (including Cancer)